Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000407424

Medchemexpress LLC Irbesartan | 138402-11-6 | 99.9% | 1 ML
SDP

Catalog No. 5000407424
Encompass_Preferred

Irbesartan (SR-47436) is an orally active Angiotensin II type 1 (AT1) receptor blocker. It helps relax blood vessels, lower blood pressure, and increase blood and oxygen supply to the heart. It is used in research for high blood pressure, heart failure, and diabetic kidney disease.

  • Inhibits Angiotensin II-induced proliferation of human aortic smooth muscle cells.
  • Inhibits human MATE1-mediated ASP+ uptake in HEK293 cells.
  • Acts as an antagonist to Angiotensin II, inhibiting its increase in cytosolic calcium concentration.
  • Reduces and suppresses Th22 cells chemotaxis and differentiation.
  • Inhibits Th22 cells related proinflammatory responses in TECs.

Catalog No. 50-004-07424 Supplier Medchemexpress LLC Supplier No. HYB020210MM/1ML
May include imposed supplier surcharges.
Add to Cart
Add to Cart

Irbesartan (SR-47436) is an orally active Angiotensin II type 1 (AT1) receptor blocker. It helps relax blood vessels, lower blood pressure, and increase blood and oxygen supply to the heart. It is used in research for high blood pressure, heart failure, and diabetic kidney disease.

  • Inhibits Angiotensin II-induced proliferation of human aortic smooth muscle cells.
  • Inhibits human MATE1-mediated ASP+ uptake in HEK293 cells.
  • Acts as an antagonist to Angiotensin II, inhibiting its increase in cytosolic calcium concentration.
  • Reduces and suppresses Th22 cells chemotaxis and differentiation.
  • Inhibits Th22 cells related proinflammatory responses in TECs.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.